Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease
Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …
Brain glucose transporters: role in pathogenesis and potential targets for the treatment of Alzheimer's disease
L Szablewski - International Journal of Molecular Sciences, 2021 - mdpi.com
The most common cause of dementia, especially in elderly people, is Alzheimer's disease
(AD), with aging as its main risk factor. AD is a multifactorial neurodegenerative disease …
(AD), with aging as its main risk factor. AD is a multifactorial neurodegenerative disease …
Subjective cognitive decline in cognitively normal elders from the community or from a memory clinic: differential affective and imaging correlates
A Perrotin, R La Joie, V de La Sayette, L Barré… - Alzheimer's & …, 2017 - Elsevier
Introduction Subjective cognitive decline (SCD) could indicate preclinical Alzheimer's
disease, but the existing literature is confounded by heterogeneous approaches to studying …
disease, but the existing literature is confounded by heterogeneous approaches to studying …
[HTML][HTML] Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer's disease
Cerebral glucose homeostasis deregulation has a role in the pathogenesis and the
progression of Alzheimer's disease (AD). Current therapies delay symptoms without …
progression of Alzheimer's disease (AD). Current therapies delay symptoms without …
Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population
QY Dong, TR Li, XY Jiang, XN Wang, Y Han… - Alzheimer's Research & …, 2021 - Springer
Introduction Subjective cognitive decline (SCD) represents a cognitively normal state but at
an increased risk for developing Alzheimer's disease (AD). Recognizing the glucose …
an increased risk for developing Alzheimer's disease (AD). Recognizing the glucose …
[HTML][HTML] Gut microbiota is an impact factor based on the brain-gut axis to alzheimer's disease: A systematic review
B Zou, J Li, RX Ma, XY Cheng, RY Ma, TY Zhou… - Aging and …, 2023 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a degenerative disease of the central nervous system. The
pathogenesis of AD has been explained using cholinergic, β-amyloid toxicity, tau protein …
pathogenesis of AD has been explained using cholinergic, β-amyloid toxicity, tau protein …
Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer's disease
The primary method for measuring brain metabolism in humans is positron emission
tomography (PET) imaging using the tracer 18F-fluorodeoxyglucose (FDG). Standardized …
tomography (PET) imaging using the tracer 18F-fluorodeoxyglucose (FDG). Standardized …
Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture
W Liu, P Zhuo, L Li, H Jin, B Lin, Y Zhang… - Free Radical Biology …, 2017 - Elsevier
An essential feature of Alzheimer's disease (AD) is implicated in brain energy metabolic
impairment that is considered underlying pathogenesis of cognitive impairment. Therefore …
impairment that is considered underlying pathogenesis of cognitive impairment. Therefore …
Reduced cerebral glucose uptake in an Alzheimer's rat model with glucose-weighted chemical exchange saturation transfer imaging
P Chen, Z Shen, Q Wang, B Zhang… - Frontiers in Aging …, 2021 - frontiersin.org
A correlation between the abnormal cerebral glucose metabolism and the progression of
Alzheimer's disease (AD) has been found in previous studies, suggesting that glucose …
Alzheimer's disease (AD) has been found in previous studies, suggesting that glucose …
The role of microRNA-34 family in Alzheimer's disease: A potential molecular link between neurodegeneration and metabolic disorders
Growing evidence indicates that overexpression of the microRNA-34 (miR-34) family in the
brain may play a crucial role in Alzheimer's disease (AD) pathogenesis by targeting and …
brain may play a crucial role in Alzheimer's disease (AD) pathogenesis by targeting and …